// App-Quantinova.ai

P342 : Trans-continental analysis of over 2000 Inflammatory Bowel Disease patients implicates geography, disease type, and exposure to immunosuppression as drivers of SARS-CoV-2 seroprevalence: data from the ICARUS-IBD Consortium

Researchers

Presenter

  • Wong, S.Y

Principal Investigators

  • Marlow, L

  • Martinez Pazos, V

  • Brann, S

  • Wellens, J

  • Kedia, S

  • Mak , J.W.Y

  • Bergemalm, D

  • Argollo, M

  • Zaltman, C

  • Steinwurz, F

  • Rubin, D

  • Allez, M

  • Halfvarson, J

  • Abreu, M.T

  • Lindsay, J

  • Dutta, U

  • Silverberg

  • Ng, S.C

  • Ahuja, V

  • Watanabe, K

  • Vermeire, S

  • Colombel, J.F

  • Satsangi, J

Medical Centers

  • Mount Sinai Hospital, The Henry D. Janowitz Division of Gastroenterology- Department of Medicine, New York, United States

  • Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States

  • University of Oxford, Translational Gastro-Intestinal Unit- Nuffield Department of Medicine, Oxford, United Kingdom

  • University Hospitals Leuven, Translational Research for Gastrointestinal Diseases, Leuven, Belgium

  • All India Institute of Medical Sciences, Gastroenterology and Human Nutrition, New Delhi, India

  • The Chinese University of Hong Kong, Medicine & Therapeutics, Hong Kong, China

  • Orebro University, Department of Gastroenterology, Faculty of Medicine and Health, Orebro, Sweden

  • Universidade Federal de Sao Paulo, Department of Psychobiology, Sao Paulo, Brazil

  • Hospital Universitário- Universidade Federal Do Rio de Janeiro, Departamento de Clínica Médica, Rio de Janeiro, Brazil

  • Instituto Steinwurz de Saúde do Intestino, Division of Gastroenterology and Hepatology, São Paulo, Brazil

  • University of Chicago Medical Center, Section of Gastroenterology, Hepatology and Nutrition, Chicago, United States

  • Hôpital Saint-Louis- APHP- Université de Paris, Gastroenterology, Paris, France

  • University of Miami Miller School of Medicine, Gastroenterology- Department of Medicine, Miami, United States

  • Barts Health NHS Trust – The Royal London Hospital, Centre for Immunobiology, London, United Kingdom

  • Postgraduate Institute of Medical Education & Research, Gastroenterology, Chandigarh, India

  • University of Toronto, Division of Gastroenterology- Mount Sinai Hospital Inflammatory Bowel Disease Centre, Toronto, Canada

  • Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine, Nishinomiya, Japan

  • University Hospital Leuven and Catholic University Leuven, Gastroenterology & Hepatology, Leuven, Belgium

  • University of Oxford, TGU, Nuffield Dept of Medicine, Oxford, United Kingdom

  • ICARUS-IBD Consortiu

Locations

  • United States

  • United Kingdom

  • Belgium

  • India

  • China

  • Sweden

  • Brazil

  • France

  • Canada

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Gastroenterology (GU)

  • Genetic Disorder

Disease

  • Inflammatory bowel disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved